Cayman Chemical

Name

Cayman Chemical

Website

https://caymanchem.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Life Sciences Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)

SIC

Medicinal Chemicals & Botanical Products (2833), In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Pharmaceutical Preparations (2834)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Analytical Instruments & Chromatography Systems (HLAGAIAA), Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG), Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI)

Keywords

• Biochemical reagents
• Assay kits
• CGMP manufacturing
• Contract research services
• Pharmaceutical intermediates

Headquarters

HQ city

Ann Arbor

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Biochemical Reagents and Assay Kits: Sale of specialized biochemical reagents including lipids, enzymes, assay kits, and ELISA kits for research applications in academia, government research institutes, and biopharmaceutical R&D
2. cGMP Manufacturing Services: Contract manufacturing services for pharmaceutical APIs and intermediates under cGMP conditions, serving biopharmaceutical companies and CDMOs
3. Contract Research Services: Fee-for-service offerings including bioanalysis, medicinal chemistry, chemical analysis, and chemical synthesis services

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Cayman Chemical manufactures and supplies specialized biochemical reagents, lipids, assay kits (e.g., ELISA kits, Reporter Assay Panels), recombinant proteins, active pharmaceutical ingredients, and forensic reference standards. The company complements these catalog products with contract research services spanning bioanalysis, medicinal chemistry, chemical synthesis, and chemical analysis, and cGMP-compliant API manufacturing for pharmaceutical and biopharmaceutical clients.

Product overview

Cayman Chemical is a life sciences company offering a broad portfolio of biochemical research products and contract research services. The core product offering spans specialized lipids, active pharmaceutical ingredients (APIs), biochemical reagents including assay kits (such as DHEA-S ELISA Kit and Reporter Assay Panels), recombinant proteins (such as Raptin Human Recombinant), and laboratory equipment. These products are complemented by comprehensive contract service divisions covering bioanalysis, medicinal chemistry, chemical analysis, and chemical synthesis. The company maintains cGMP manufacturing capabilities for pharmaceutical API production and offers dedicated forensic chemistry and toxicology services. Scientific literature resources including application notes, case studies, and webinars support customer adoption across research areas spanning cancer, cardiovascular, cell biology, lipid biochemistry, neuroscience, and infectious disease research.

Differentiator

Problem solved

Functional benefit

Products and services

• Lipids Specialized lipid products including fatty acids, phospholipids, and lipid derivatives sold for life science research applications across cancer, cardiovascular, neuroscience, and lipid biochemistry research areas.
• Active Pharmaceutical Ingredients (APIs) Active pharmaceutical ingredients including cGMP-manufactured APIs supplied to pharmaceutical clients for drug development and commercial supply.
• Biochemical Reagents Catalog of biochemical reagents including assay kits (e.g., DHEA-S ELISA Kit, Reporter Assay Panels), enzyme inhibitors, receptor ligands, and research chemicals for life science research applications.
• cGMP Manufacturing Services Good Manufacturing Practice (cGMP) compliant contract API manufacturing, testing, and quality services for pharmaceutical and biopharmaceutical clients.
• Contract Research Services Comprehensive fee-for-service offerings covering bioanalysis, medicinal chemistry, chemical analysis, and chemical synthesis for drug discovery and development clients.
• Forensic Chemistry & Toxicology Services Specialized forensic analytical services for drug testing, toxicology analysis, and quality assurance delivered to forensic and clinical laboratory customers.
• Forensic Reference Standards Certified reference materials and standards used for forensic and clinical laboratory testing applications.
• Laboratory Equipment Laboratory equipment and instruments supplied for biochemical analysis and research workflows.

Quantifiable outcome

• Achieved 99.6% pharma-grade purity with 99% feedstock conversion in pilot-scale production
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• eXoZymes Inc.coreStrategic or Co-development Partner · 29 January 2026Cayman Chemical served as the external manufacturing partner for eXoZymes' first end-to-end pilot production run of N-trans-caffeoyltyramine (NCT). The partnership successfully demonstrated the transferability and scalability of eXoZymes' cell-free biomanufacturing technology, achieving 99% feedstock conversion, 91% process recovery, 90% isolated yield, and 535 grams of product at 99.6% pharma-grade purity. The successful scale-up from 1-liter to 100-liter validates that the technology can be operated by external partners.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Regional players

• Cayman Pharma (previously known operations): Cayman-branded pharmaceutical operations (separate entity) addressing APIs and intermediates with adjacent capabilities in regulated chemical supply.

Broad incumbents

• Sigma-Aldrich (MilliporeSigma): Largest life science reagents and biochemicals supplier (part of Merck KGaA) offering broader catalog across analytical chemistry, reagents, and lab consumables.
• Thermo Fisher Scientific: Diversified life sciences giant offering reagents, assay kits, lab instruments, and CDMO services with overlapping product lines and a much broader portfolio.

Direct peers

• Bio-Techne: Major life science reagents and assay kits provider (including R&D Systems and Tocris Bioscience brands) with overlapping reagent, protein, and ELISA kit offerings serving academic and biopharma researchers globally.
• MedChemExpress: Specialty biochemicals, inhibitors, and research reagents supplier competing directly with Cayman in catalog biochemicals and small molecules for life science research.
• Abcam: Supplies antibodies, reagents, kits, and biochemicals to academic and biopharma researchers with a similar direct-to-scientist e-commerce and catalog model.
• Santa Cruz Biotechnology: Research reagent supplier offering antibodies, biochemicals, and lab products to academic and pharma research customers with overlapping catalog coverage.
• Enzo Life Sciences: Provides life science research reagents, assay kits, and biochemicals with comparable product categories in immunology, cell biology, and drug discovery.
• Avanti Polar Lipids: Specialty lipid manufacturer and supplier to research and pharmaceutical customers — directly comparable to Cayman lipid product line for life science and drug delivery research.

Others

• Cayman Chemical Services (Cayman Pharma): Adjacent Cayman-branded entity providing cGMP API manufacturing services, comparable to Cayman's cGMP Manufacturing Services revenue stream and contract research offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/CaymanChemical
• Facebookfacebook.com/CaymanChemical

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cayman Chemical